Advancing Antibody Discovery with True Multiplex Screening and the iQue Screener PlatformWednesday, 10 February 2016 at 12:15  Add to Calendar ▼2016-02-10 12:15:002016-02-10 13:15:00Europe/LondonAdvancing Antibody Discovery with True Multiplex Screening and the iQue Screener PlatformAntibodies in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.comMultiplexed high throughput screening is becoming an integral component in the discovery of therapeutic antibodies because it increases confidence in screening hits, improves workflow and enables the identification of lead candidates with increased functionality. With the iQue Screener platform, scientists are using suspension assay formats and encoding technology to develop powerful high content screens for their antibody libraries. |
Add to Calendar ▼2016-02-09 00:00:002016-02-10 00:00:00Europe/LondonAntibodies in Drug DiscoveryAntibodies in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com
